Complete Genomics Inc. (GNOM) was chosen by Mayo Clinic's Center for Individualized Medicine to provide whole human genome sequencing outsourcing services, to supplement the nonprofit research hospital's in-house gene-sequencing laboratory. Complete Genomics shares rose nearly 24% to $4.07 in recent premarket trading. Through Friday's close, the stock is up nearly 49% from its all-time low in January, as the sector received a big lift from Swiss drug giant Roche Holding Ltd.'s (ROG.VX) hostile offer for Illumina Inc. (ILMN), which makes tools for DNA sequencing.

Wall Street Journal, 02/13/2012

Additional coverage: Wall St. Cheat Sheet, CBS News, Reuters, GenomeWeb

Tags: Complete Genomics Inc., Finanical, Genomics, GNOM, human genome sequencing outsourcing services, Illumina Inc., ILMN, Mayo Clinc's Center for Individualized Medicine, Roche Holding Ltd., ROG.VX